Hiroishi Kazumasa, Ito Takayoshi, Imawari Michio
Department of Gastroenterology, Showa University School of Medicine, Tokyo, Japan.
J Gastroenterol Hepatol. 2008 Oct;23(10):1473-82. doi: 10.1111/j.1440-1746.2008.05475.x. Epub 2008 Aug 28.
Immune responses against hepatitis C virus (HCV) play a crucial role in the pathogenesis of chronic hepatitis C. HCV infection often persists and leads to chronic hepatitis and eventually cirrhosis. Accumulated data suggest that HCV proteins suppress host immune responses through the suppression of functions of immune cells, such as cytotoxic T lymphocytes, natural killer cells, and dendritic cells. They also suppress the type 1 interferon signaling system. The resulting insufficient immune responses against HCV lead to the sustained infection. The appropriate control of immune responses would contribute to the eradication of HCV and the improvement of hepatitis, but there are still many issues to be clarified. This review describes the scientific evidence to support these emerging concepts, and will touch on the implications for improving antiviral therapy.
针对丙型肝炎病毒(HCV)的免疫反应在慢性丙型肝炎的发病机制中起着关键作用。HCV感染通常会持续存在,并导致慢性肝炎,最终发展为肝硬化。积累的数据表明,HCV蛋白通过抑制免疫细胞(如细胞毒性T淋巴细胞、自然杀伤细胞和树突状细胞)的功能来抑制宿主免疫反应。它们还抑制1型干扰素信号系统。由此产生的针对HCV的免疫反应不足导致持续感染。对免疫反应的适当控制将有助于根除HCV并改善肝炎状况,但仍有许多问题有待阐明。本综述描述了支持这些新出现概念的科学证据,并将探讨其对改进抗病毒治疗的意义。